164 related articles for article (PubMed ID: 27780144)
1. Fructose-1,6-bisphosphatase is a novel regulator of Wnt/β-Catenin pathway in breast cancer.
Li K; Ying M; Feng D; Du J; Chen S; Dan B; Wang C; Wang Y
Biomed Pharmacother; 2016 Dec; 84():1144-1149. PubMed ID: 27780144
[TBL] [Abstract][Full Text] [Related]
2. A Noncanonical Role of Fructose-1, 6-Bisphosphatase 1 Is Essential for Inhibition of Notch1 in Breast Cancer.
Lu C; Ren C; Yang T; Sun Y; Qiao P; Wang D; Lv S; Yu Z
Mol Cancer Res; 2020 May; 18(5):787-796. PubMed ID: 32041737
[TBL] [Abstract][Full Text] [Related]
3. Fibulin-5 inhibits Wnt/β-catenin signaling in lung cancer.
Chen X; Song X; Yue W; Chen D; Yu J; Yao Z; Zhang L
Oncotarget; 2015 Jun; 6(17):15022-34. PubMed ID: 25909283
[TBL] [Abstract][Full Text] [Related]
4. Warburg effect revisited: an epigenetic link between glycolysis and gastric carcinogenesis.
Liu X; Wang X; Zhang J; Lam EK; Shin VY; Cheng AS; Yu J; Chan FK; Sung JJ; Jin HC
Oncogene; 2010 Jan; 29(3):442-50. PubMed ID: 19881551
[TBL] [Abstract][Full Text] [Related]
5. Fructose-1, 6-bisphosphatase 1 interacts with NF-κB p65 to regulate breast tumorigenesis via PIM2 induced phosphorylation.
Lu C; Ren C; Yang T; Sun Y; Qiao P; Han X; Yu Z
Theranostics; 2020; 10(19):8606-8618. PubMed ID: 32754266
[No Abstract] [Full Text] [Related]
6. Inhibiting histone deacetylases suppresses glucose metabolism and hepatocellular carcinoma growth by restoring FBP1 expression.
Yang J; Jin X; Yan Y; Shao Y; Pan Y; Roberts LR; Zhang J; Huang H; Jiang J
Sci Rep; 2017 Mar; 7():43864. PubMed ID: 28262837
[TBL] [Abstract][Full Text] [Related]
7. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
Kong LY; Xue M; Zhang QC; Su CF
Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-1 down-regulates proliferation and migration of breast cancer stem cells by inhibiting the Wnt/β-catenin pathway.
Liu T; Hu K; Zhao Z; Chen G; Ou X; Zhang H; Zhang X; Wei X; Wang D; Cui M; Liu C
Oncotarget; 2015 Dec; 6(39):41638-49. PubMed ID: 26497855
[TBL] [Abstract][Full Text] [Related]
9. Expression and the clinical significance of Wnt10a and Wnt10b in endometrial cancer are associated with the Wnt/β-catenin pathway.
Chen H; Wang Y; Xue F
Oncol Rep; 2013 Feb; 29(2):507-14. PubMed ID: 23135473
[TBL] [Abstract][Full Text] [Related]
10. Invalidation of mitophagy by FBP1-mediated repression promotes apoptosis in breast cancer.
Liu Y; Jiang Y; Wang N; Jin Q; Ji F; Zhong C; Zhang Z; Yang J; Ye X; Chen T
Tumour Biol; 2017 Jun; 39(6):1010428317708779. PubMed ID: 28653874
[TBL] [Abstract][Full Text] [Related]
11. A tRNA fragment, 5'-tiRNA
Mo D; Jiang P; Yang Y; Mao X; Tan X; Tang X; Wei D; Li B; Wang X; Tang L; Yan F
Cancer Lett; 2019 Aug; 457():60-73. PubMed ID: 31078732
[TBL] [Abstract][Full Text] [Related]
12. β-catenin regulates c-Myc and CDKN1A expression in breast cancer cells.
Xu J; Chen Y; Huo D; Khramtsov A; Khramtsova G; Zhang C; Goss KH; Olopade OI
Mol Carcinog; 2016 May; 55(5):431-9. PubMed ID: 25663530
[TBL] [Abstract][Full Text] [Related]
13. Wnt/β-catenin signaling pathway upregulates c-Myc expression to promote cell proliferation of P19 teratocarcinoma cells.
Zhang S; Li Y; Wu Y; Shi K; Bing L; Hao J
Anat Rec (Hoboken); 2012 Dec; 295(12):2104-13. PubMed ID: 22976998
[TBL] [Abstract][Full Text] [Related]
14. Targeted knockdown of polo-like kinase 1 alters metabolic regulation in melanoma.
Gutteridge RE; Singh CK; Ndiaye MA; Ahmad N
Cancer Lett; 2017 May; 394():13-21. PubMed ID: 28235541
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic targeting of casein kinase 1δ in breast cancer.
Rosenberg LH; Lafitte M; Quereda V; Grant W; Chen W; Bibian M; Noguchi Y; Fallahi M; Yang C; Chang JC; Roush WR; Cleveland JL; Duckett DR
Sci Transl Med; 2015 Dec; 7(318):318ra202. PubMed ID: 26676609
[TBL] [Abstract][Full Text] [Related]
16. NBAT1 suppresses breast cancer metastasis by regulating DKK1 via PRC2.
Hu P; Chu J; Wu Y; Sun L; Lv X; Zhu Y; Li J; Guo Q; Gong C; Liu B; Su S
Oncotarget; 2015 Oct; 6(32):32410-25. PubMed ID: 26378045
[TBL] [Abstract][Full Text] [Related]
17. FBP1-Altered Carbohydrate Metabolism Reduces Leukemic Viability through Activating P53 and Modulating the Mitochondrial Quality Control System In Vitro.
Xu Y; Tran L; Tang J; Nguyen V; Sewell E; Xiao J; Hino C; Wasnik S; Francis-Boyle OL; Zhang KK; Xie L; Zhong JF; Baylink DJ; Chen CS; Reeves ME; Cao H
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232688
[TBL] [Abstract][Full Text] [Related]
18. NOP14 suppresses breast cancer progression by inhibiting NRIP1/Wnt/β-catenin pathway.
Lei JJ; Peng RJ; Kuang BH; Yuan ZY; Qin T; Liu WS; Guo YM; Han HQ; Lian YF; Deng CC; Zhang HJ; Chen LZ; Feng QS; Xu M; Feng L; Bei JX; Zeng YX
Oncotarget; 2015 Sep; 6(28):25701-14. PubMed ID: 26213846
[TBL] [Abstract][Full Text] [Related]
19. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.
Schlange T; Matsuda Y; Lienhard S; Huber A; Hynes NE
Breast Cancer Res; 2007; 9(5):R63. PubMed ID: 17897439
[TBL] [Abstract][Full Text] [Related]
20. Wnt/β-catenin pathway is required for epithelial to mesenchymal transition in CXCL12 over expressed breast cancer cells.
Shan S; Lv Q; Zhao Y; Liu C; Sun Y; Xi K; Xiao J; Li C
Int J Clin Exp Pathol; 2015; 8(10):12357-67. PubMed ID: 26722422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
